Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.


Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 3000 SOLANDT ROAD
Tel: N/A
IR: See website
Key People
Michael R. Munzar
Independent Chairman of the Board
Sebastien St-Louis
President, Chief Executive Officer, Director
Stephen Burwash
Chief Financial Officer
Donald Courtney
Chief Operating Officer
Dominique Jones
Chief People Officer
Roch Vaillancourt
General Counsel
Veronique Hamel
Chief Innovation Officer
Business Overview
Hexo Corp, formerly Hydropothecary Corp, is a Canada-based company that creates and distributes products to serve the Canadian cannabis market. The Company operates with an approximately 300,000 square feet of production capacity. The Company serves the adult-use market under the HEXO brand, while it serves its medical cannabis clients through the Hydropothecary brand. The following are the Company's products under the Hydropothecary brand: Time of Day product line, which includes dried marijuana buds for morning, midday, after dinner and bedtime; Hydrogen (H2) classical medical marijuana line, which includes Papaya Grove, Green Chai and Kush dried marijuana buds, among others; Decarb ready to consume activated marijuana powder; Elixir cannabis oil sublingual spray, as well as Fleur de Lune intimate cannabis oil.
Financial Overview
For the three months ended 31 October 2019, Hexo Corp revenues increased from C$5.7M to C$14.5M. Net loss increased from C$12.8M to C$60M. Revenues reflect Gross revenue from sale of goods increase from C$6.6M to C$19.3M. Higher net loss reflects Unrealized (loss)/gain on convertible de decrease from C$3.4M (income) to C$2.6M (expense), Realized fair value amounts on inventory increase from C$717K to C$6.7M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $400.57M as of Oct 31, 2019
Annual revenue (TTM): $56.38M as of Oct 31, 2019
EBITDA (TTM): -$95.69M as of Oct 31, 2019
Net annual income (TTM): -$116.82M as of Oct 31, 2019
Free cash flow (TTM): -$298.88M as of Oct 31, 2019
Net Debt Last Fiscal Year: $0.55M as of Oct 31, 2019
Shares outstanding: 257,206,133 as of Dec 20, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization